ANDA 76023, held by Teva. Hydrocodone Bitartrate; Ibuprofen.
As of Nov 16, 2026, ANDA 76023 (Hydrocodone Bitartrate And Ibuprofen), held by Teva, was first approved by FDA on Apr 11, 2003, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 11, 2003 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydrocodone Bitartrate And Ibuprofen7.5MG;200MG · tablet;oral | Hydrocodone Bitartrate; Ibuprofen | Discontinued |
| Sep 20, 2018 | Supplement 18Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 19REMS | Approved | None posted |
| Aug 30, 2018 | Supplement 17Labeling · Standard review | Approved | None posted |
| Apr 30, 2007 | Supplement 6Labeling | Approved | None posted |
| Apr 30, 2007 | Supplement 8Labeling | Approved | None posted |
| Apr 11, 2003 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters